Aiming higher

Expansion is our goal
We are currently the second largest parallel importer in Europe, but our vision goes beyond this. As a result we are investing heavily in our current markets, while continuing to expand into new markets:

• Building a strong presence in the Finnish market where we are currently No. 2
• A strong pipeline emerging in Switzerland and looking to be No. 1 on this new, immature market
• Building a promising partnership on the Icelandic market, a small but promising market

Involved in parallel import issues
Parallel import of pharmaceuticals is an interesting and at the same time frustrating business. We are constantly fighting for our rights and this is not always easy. We are therefore very much involved in both national and European associations. Our Managing Director, Hans Bøgh-Sørensen, is the President of the EAEPC and the entire team in the association is working hard to remove any competition distortions (i.e. quotas, dual pricing) and correct the myths that challenge both importers and exporters (i.e. parallel imports threaten R&D or that parallel imports are an entry point for counterfeits).

Hans: “Together we can accomplish much more than we can by ourselves”.

Please visit the EAEPC website for more information.